Stay updated with breaking news from Sci Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BRISBANE, Calif., Jan. 29, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious...
NEWTOWN SQUARE, Pa., Jan. 25, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to...
– Stephen Mahoney appointed President and Chief Executive Officer – – Potential best-in-class subcutaneous and intravenous thyroid eye disease programs targeting insulin-like growth factor 1...
NEW YORK, Oct. 02, 2023 -- Immunovant, Inc. , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced the closing of its...
NEW YORK, Sept. 27, 2023 -- Immunovant, Inc. , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced the pricing of an...